109 related articles for article (PubMed ID: 37986376)
1. Establishment of a 6-signature risk model associated with cellular senescence for predicting the prognosis of breast cancer.
Zhang XX; Yu X; Zhu L; Luo JH
Medicine (Baltimore); 2023 Nov; 102(46):e35923. PubMed ID: 37986376
[TBL] [Abstract][Full Text] [Related]
2. A senescence-related signature for predicting the prognosis of breast cancer: A bioinformatics analysis.
Xing T; Hu Y; Wang H; Zou Q
Medicine (Baltimore); 2023 May; 102(19):e33739. PubMed ID: 37171330
[TBL] [Abstract][Full Text] [Related]
3. A cellular senescence-related classifier based on a tumorigenesis- and immune infiltration-guided strategy can predict prognosis, immunotherapy response, and candidate drugs in hepatocellular carcinoma.
Luo Y; Liu H; Fu H; Ding GS; Teng F
Front Immunol; 2022; 13():974377. PubMed ID: 36458010
[TBL] [Abstract][Full Text] [Related]
4. Multi-omics analysis revealing a senescence-relevant lncRNAs signature for the assessment of response to immunotherapy for breast cancer.
Yu Z; Zhu Y; Ji J
Medicine (Baltimore); 2023 Jul; 102(28):e34287. PubMed ID: 37443486
[TBL] [Abstract][Full Text] [Related]
5. Identification of a Transcription Factor Signature That Can Predict Breast Cancer Survival.
Fan C; Du J; Liu N
Comput Math Methods Med; 2021; 2021():2649123. PubMed ID: 33688372
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a N1-methyladenosine-related risk signature for breast carcinoma by bioinformatics analysis and experimental validation.
Li L; Yang W; Jia D; Zheng S; Gao Y; Wang G
Breast Cancer; 2023 Jul; 30(4):666-684. PubMed ID: 37178414
[TBL] [Abstract][Full Text] [Related]
7. Leveraging senescence-oxidative stress co-relation to predict prognosis and drug sensitivity in breast invasive carcinoma.
Ye Y; Luo Y; Guo T; Zhang C; Sun Y; Xu A; Ji L; Ou J; Wu SY
Front Endocrinol (Lausanne); 2023; 14():1179050. PubMed ID: 37600707
[TBL] [Abstract][Full Text] [Related]
8. A senescence-based prognostic gene signature for colorectal cancer and identification of the role of SPP1-positive macrophages in tumor senescence.
Yu S; Chen M; Xu L; Mao E; Sun S
Front Immunol; 2023; 14():1175490. PubMed ID: 37090726
[TBL] [Abstract][Full Text] [Related]
9. Identification of senescence-related subtypes, establishment of a prognosis model, and characterization of a tumor microenvironment infiltration in breast cancer.
Zhou Y; Xiao L; Long G; Cao J; Liu S; Tao Y; Zhou L; Tang J
Front Immunol; 2022; 13():921182. PubMed ID: 36072578
[TBL] [Abstract][Full Text] [Related]
10. Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy.
Hong K; Cen K; Chen Q; Dai Y; Mai Y; Guo Y
Front Immunol; 2023; 14():1128390. PubMed ID: 36761753
[TBL] [Abstract][Full Text] [Related]
11. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network.
Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D
Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658
[TBL] [Abstract][Full Text] [Related]
12. Identification of a pyroptosis-related prognostic signature in breast cancer.
Chen H; Luo H; Wang J; Li J; Jiang Y
BMC Cancer; 2022 Apr; 22(1):429. PubMed ID: 35443644
[TBL] [Abstract][Full Text] [Related]
13. Establishment of three heterogeneous subtypes and a risk model of low-grade gliomas based on cell senescence-related genes.
Chen J; Wu L; Yang H; Zhang X; Xv S; Qian Q
Front Immunol; 2022; 13():982033. PubMed ID: 36052073
[TBL] [Abstract][Full Text] [Related]
14. Cellular senescence-related long noncoding ribonucleic acids: Predicting prognosis in hepatocellular carcinoma.
Huang H; Yao H; Wei Y; Chen M; Sun J
Cancer Rep (Hoboken); 2023 Apr; 6(4):e1791. PubMed ID: 36726348
[TBL] [Abstract][Full Text] [Related]
15. Identification of prognostic biomarkers of breast cancer based on the immune-related gene module.
Wang R; Zeng H; Xiao X; Zheng J; Ke N; Xie W; Lin Q; Zhang H
Autoimmunity; 2023 Dec; 56(1):2244695. PubMed ID: 37584152
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel senescence-associated signature to predict biochemical recurrence and immune microenvironment for prostate cancer.
Han C; Deng Y; Yang B; Hu P; Hu B; Wang T; Liu J; Xia Q; Liu X
Front Immunol; 2023; 14():1126902. PubMed ID: 36891298
[TBL] [Abstract][Full Text] [Related]
17. A novel cell senescence-related IncRNA survival model associated with the tumor immune environment in colorectal cancer.
Xu C; Li F; Liu Z; Yan C; Xiao J
Front Immunol; 2022; 13():1019764. PubMed ID: 36275644
[TBL] [Abstract][Full Text] [Related]
18. A cellular senescence-related genes model allows for prognosis and treatment stratification of cervical cancer: a bioinformatics analysis and external verification.
Yang W; An L; Li Y; Qian S
Aging (Albany NY); 2023 Sep; 15(18):9408-9425. PubMed ID: 37768206
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive genomics analysis of aging related gene signature to predict the prognosis and drug resistance of colon adenocarcinoma.
Feng J; Fu F; Nie Y
Front Pharmacol; 2023; 14():1121634. PubMed ID: 36925638
[No Abstract] [Full Text] [Related]
20. Genes associated with cellular senescence favor melanoma prognosis by stimulating immune responses in tumor microenvironment.
Liang X; Lin X; Lin Z; Lin W; Peng Z; Wei S
Comput Biol Med; 2023 May; 158():106850. PubMed ID: 37031510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]